Clinical Trials Browser

Phase 1/2 × OTHER × famitinib × Clear all

NCT06332950 2024-03-27

Safety and Efficacy of Adebrelimab Plus Irinotecan Liposome (II) With or Without Famitinib in ES-SCLC Pre-treated With Immunotherapy

Phase 1/2 Not yet recruiting

Small Cell Lung Carcinoma

NCT04044378 2020-05-19

Famitinib Plus Camrelizumab & Famitinib Alone & Famitinib Plus Ifosfamide in Advanced Osteosarcoma

Phase 1/2 Withdrawn

Neoplasms, Disease Progression